|
Vioxx...

Merck & Co., the maker of Vioxx® is pulling its best-selling arthritis drug off
the market based on data indicating the drug increases the risk of heart attack
and stroke among users.
The company announced on September 30, 2004 the immediate, voluntary worldwide
withdrawal after a three-year colon cancer clinical trial revealed that patients
taking Vioxx® had test results showing an increased risk of heart attacks and
other cardiovascular complications. The FDA found that people taking the
recommended dose of Vioxx were at 3 times the risk of heart attack and sudden
death compared to persons taking other, non-steroidal painkillers. Further,
those taking Vioxx® had a 50% greater chance of sudden cardiac death or heart
attack than those using Pfizer’s Celebrex®, a rival medicine. Vioxx® has also
been associated with several other life-threatening side effects, including
blood clots, angina and nonbacterial meningitis, severe intestinal damage,
ulcerations and bleeding, and kidney damage.
If you have suffered a heart attack or stroke while on Vioxx®, please fill out our
claim form.

News...
|